Cellectar Biosciences Inc... (CLRB)
NASDAQ: CLRB
· Real-Time Price · USD
5.69
-0.11 (-1.90%)
At close: Oct 03, 2025, 3:59 PM
5.78
1.58%
After-hours: Oct 03, 2025, 05:54 PM EDT
Cellectar Biosciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 11.04M | 13.91M | 23.29M | 34.26M | 25.87M | 40.03M | 9.56M | 18.99M | 5.15M | 12.68M | 19.87M | 17.79M | 24.81M | 30.63M | 35.7M | 40.34M | 46.78M | 53.63M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 29.78K | 69.43K | 81.21K | 81.21K | 81.21K | 81.21K | 81.21K | 81.21K | 81.21K | 81.21K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.58M | 987.5K | 961.66K | 1.64M | 2.04M | 1.34M | 888.23K | 1.12M | 456.68K | 1.16M | 663.24K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 12.62M | 14.89M | 24.25M | 35.9M | 27.91M | 41.37M | 10.45M | 20.11M | 5.61M | 13.85M | 20.53M | 18.76M | 25.29M | 31.39M | 36.57M | 41.39M | 47.12M | 54.4M |
Property-Plant & Equipment | 1.05M | 1.12M | 1.19M | 1.36M | 1.45M | 1.51M | 1.59M | 1.41M | 869.73K | 922.59K | 978.98K | 477.04K | 525.95K | 514.43K | 549.13K | 479.25K | 531.76K | 581.96K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.08M | 1.15M | 1.22M | 1.39M | 1.48M | 1.54M | 1.62M | 1.44M | 899.51K | 992.02K | 1.06M | 558.25K | 607.16K | 595.64K | 630.35K | 560.46K | 612.98K | 663.17K |
Total Assets | 13.7M | 16.04M | 25.47M | 37.29M | 29.38M | 42.91M | 12.08M | 21.55M | 6.51M | 14.84M | 21.59M | 19.32M | 25.89M | 31.99M | 37.2M | 41.95M | 47.74M | 55.06M |
Account Payables | 4.68M | 3.87M | 7.59M | 8.3M | 6.46M | 7.39M | 9.18M | 7.81M | 6.39M | 6.9M | 5.48M | 6.37M | 5.46M | 4.51M | 3.85M | 3.03M | 3.39M | 4.9M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 1.1M | 2.06M | 1.72M | 11.93M | 8.63M | 21.08M | 16.12M | 8.6M | n/a | n/a | 5.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 5.87M | 6.02M | 9.39M | 20.31M | 15.17M | 28.55M | 25.36M | 16.47M | 6.45M | 6.96M | 11.5M | 6.52M | 5.61M | 4.65M | 3.99M | 3.17M | 3.52M | 5.02M |
Long-Term Debt | 361.49K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 1.38M | 1.38M | 1.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 361.49K | 1.77M | 1.79M | 1.81M | 453.51K | 474.35K | 494K | 512.75K | 530.86K | 548.34K | 552.98K | 53.77K | 92.21K | 129.71K | 166.29K | 201.97K | 236.06K | 269.31K |
Total Liabilities | 6.23M | 7.79M | 11.18M | 22.13M | 15.62M | 29.03M | 25.85M | 16.98M | 6.98M | 7.5M | 12.05M | 6.57M | 5.7M | 4.78M | 4.16M | 3.37M | 3.75M | 5.29M |
Total Debt | 453.51K | 474.35K | 494K | 512.75K | 530.86K | 548.34K | 552.98K | 569.01K | 584.5K | 599.45K | 603.83K | 201.97K | 236.06K | 269.31K | 301.74K | 333.38K | 363.53K | 392.95K |
Book Value | 7.47M | 8.25M | 14.29M | 15.16M | 13.76M | 13.88M | -13.78M | 4.57M | -467K | 7.33M | 9.54M | 12.75M | 20.19M | 27.21M | 33.05M | 38.59M | 43.98M | 49.78M |
Book Value Per Share | 4.64 | 5.37 | 9.31 | 11.57 | 11.53 | 14.19 | -21.28 | 12.12 | -1.24 | 19.54 | 30.74 | 62.60 | 991.51 | 133.59 | 162.25 | 193.35 | 250.08 | 310.20 |
Common Stock | 18.00 | 461.00 | 461.00 | 406.00 | 358.00 | 332.00 | 207.00 | 99.00 | 97.00 | 97.00 | 94.00 | 61.00 | 61.00 | 611.00 | 611.00 | 611.00 | 553.00 | 527.00 |
Retained Earnings | -259.39M | -253.95M | -247.34M | -244.99M | -230.32M | -229.4M | -202.76M | -210.03M | -196.3M | -188.08M | -159.99M | -172.28M | -164.47M | -157.04M | -150.9M | -144.98M | -139.16M | -133.13M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 7.47M | 8.25M | 14.29M | 15.16M | 13.76M | 13.88M | -13.78M | 4.57M | -467K | 7.33M | 9.54M | 12.75M | 20.19M | 27.21M | 33.05M | 38.59M | 43.98M | 49.78M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |